ABSTRACT: The gluconeogenic contribution to glucose production in livers isolated from rats fasted for 24 h was determined by 13 H-NMR analysis of the gluconeogenic contribution to glucose production (100 AE 1% and 99 AE 1%, respectively) and consistent with the expected negligible contribution from glycogenolysis. These results indicate that 13 C-NMR analysis of glucose 13 C-isotopomer distribution from either [ 13 C]bicarbonate or [1-
INTRODUCTION
During fasting, hepatic glucose is produced by glycogen hydrolysis and gluconeogenesis (GNG). Rates of hepatic glucose synthesis from these sources are influenced by nutritional, hormonal and disease states. Therefore, measurement of these fluxes provides key insights into relationships between glucose metabolism and wholebody physiology and pathophysiology. Traditionally, GNG has been measured by comparing the enrichment or specific radioactivity of a representative precursor substrate, such as alanine or lactate, with that of plasma glucose after infusion of 13 C-or 14 C-labeled alanine or lactate tracer. However, with this approach, three factors reduce the precision of the measurement: (1) true hepatic precursor enrichment is difficult to measure in situ; (2) there is unspecified loss and dilution of the tracer by exchange with Krebs cycle intermediates; (3) the contributions of glycerol GNG and glycogenolysis to glucose production (GP) cannot be resolved, as both processes dilute the 13 C enrichment or 14 C specific radioactivity of plasma glucose relative to that of the precursor pool. Mass isotopomer distribution analysis (MIDA) overcomes these limitations by relating the tracer enrichment of plasma glucose to that of the immediate triose phosphate precursors (1, 2) . As any dilution of the tracer between triose phosphate and glucose can only arise from unlabeled glucose generated by glycogenolysis, the method provides a measurement of the total GNG contribution to GP relative to glycogenolysis. The measurement is also practical in that enrichment of triose phosphate precursor is calculated from the isotopomer distribution of plasma glucose, eliminating the need to measure the enrichment of hepatic precursor pools. A key assumption of MIDA is that the tracer has equal access to all hepatic GNG activity. One of the conditions is that the tracer arteriovenous concentration gradient across the hepatic lobule must be relatively small so that periportal and perivenous hepatocytes have equal access to the tracer. This applies for some substrates such as lactate, but not for other GNG precursors that are quantitatively extracted from the circulation by the liver, such as glycerol (3, 4 13 C signals of glucose represent background natural abundance (NA) at 1.1%, and, as such, they provide convenient internal standards for estimating excess 13 C enrichment in C3 and C4 of glucose. Thus, by comparing the actual glucose enrichment with that of the triose phosphate precursor derived by isotopomer distribution analysis, the fraction of glucose derived from triose phosphate (assumed to be equal to the fraction derived by GNG) can be estimated.
[Glycogen conversion into glucose is assumed to occur entirely via the direct pathway (glycogen ! Glc1P ! Glc6P ! glucose). Any glycogen that is converted into C3 compounds before Glc6P and glucose will be counted as To determine if this approach provides realistic estimates of the GNG contribution to GP, we applied the method to perfused livers obtained from rats fasted for 24 h, in which the contribution of GNG to GP is expected to approach 100%. We compared this method with the 2 H 2 O measurement of fractional GNG based on the 2 H-enrichment ratio in positions 5 and 2 of glucose (H5/H2). In either perfused or in situ livers depleted of glycogen, the H5/H2 ratio provides realistic estimates of the fraction of GP derived from GNG (i.e. approaching 100% contribution). This ratio can be derived by 2 H-NMR spectroscopy of the MAG derivative without interference from the 13 C-enrichment distributions (7) (8) (9) (10) (11) . Likewise, the [ 
MATERIALS AND METHODS

Experimental design
Healthy male Wistar Han rats, 12 weeks old, were purchased from Charles River Laboratories, Barcelona, Spain. After being starved for 24 h, the animals were randomly divided into two groups. Before liver removal, each animal was anesthetized with an intraperitoneal injection of ketamine (200 mL/100 g body weight). Then, with the portal vein cannulated, each liver was perfused (>20 mL/min for 10 min) with Krebs-Henseleit bicarbonate/H 2 O buffer bubbled continuously with a 95%/5% mixture of O 2 /CO 2 at 378C. After this wash-out period, the livers of one group were perfused (>20 mL/min for 20 min) with Krebs-Henseleit [ The perfusates obtained were lyophilized, and all the glucose present in the extracts was converted into MAG as described by Snowden (12) . The lyophilized extracts were treated with excess anhydrous deuterated acetone and concentrated H 2 SO 4 (4%, v/v) and stirred for 4 h. Water was then added to the reaction mixture, and the sample was neutralized with 2 M NaOH. The pH was then adjusted to 2.0 with dilute HCl, and the solution was kept for 5 h at 408C. The reaction was stopped by elevating the pH to 8-9 with 2 M NaOH, and the solvent was removed by rotary evaporation. MAG was extracted from the dried residue with a few milliliters of boiling ethyl acetate, and the residue of the new extraction was dissolved in 600 mL 90% acetonitrile/10% water.
NMR analysis
NMR spectra were acquired using a 5 mm broadband probe on a 11.7 T Varian Unity spectrometer (Varian Instruments, Palo Alto, CA, USA) at 508C. Protondecoupled 13 C-NMR spectra of liver and perfusate samples were acquired using a 458 pulse, a 1.5 s acquisition time, and an interpulse delay of 3 s. Proton-decoupled 2 H NMR spectra of the perfusate samples were obtained in the unlocked mode using a 908 pulse, a 1.5 s acquisition time, and no interpulse delay. Deconvolution and quantification of Contribution of GNG to hepatic GP by isotopomer distribution analysis of glucose enrichment from 13 
C-labeled tracers
The percentage 13 C enrichment of glucose in C3 and C4 (Glc3F, Glc4F) was determined by the ratio of the total C3 or C4 signal relative to the neighboring NA C2 or C5 signals multiplied by 100. Excess 13 C enrichment in C3 and C4 was determined by subtracting 1.1% from Glc3F and Glc4F.
Triose phosphate precursor enrichment, x n , was estimated from the C3 multiplet (x 3 ) and C4 (x 4 ) multiplet by the following equations:
(1)
where C3S and C4S are the relative areas of the C3 and C4 singlet signals after subtraction of NA contributions, and C3D34 and C4D34 are the relative areas of the C3 and C4 doublet signals.
The percentage of glucose derived from GNG was calculated from the triose phosphate and glucose enrichments of C3 and C4 as follows:
Percentage glucose from GNG; C3 analysis
Percentage glucose from GNG; C4 analysis
From the 2 H NMR spectra of MAG, the percentage contribution of glycogenolysis and GNG was evaluated by the ratio of deuterium signal intensities of positions 2 and 5 according to the following equation [7] : Glycogenolysis contribution to GP : ½1 À ðsignal 5=signal 2Þ Â 100
GNG contribution to GP : ðsignal 5=signal 2Þ Â 100 (6)
Data presentation and statistical analysis
The results are presented as mean AE SE. A statistical analysis was performed using the Mann-Whitney U test, a non-parametric alternative to the t test for independent samples. In this test, two populations are considered statistically different if U calc ! U table .
RESULTS
Glucose enrichment from [ 13 C]bicarbonate and [1-
13 C]lactate assessed by 13 
C NMR
The MAG derivative generates narrow and well-resolved C enrichment of C3 tended to be higher than that of C4 ( Table 1 ), indicating that 13 C enrichment was not completely equilibrated between glyceraldehyde 3-phosphate and dihydroxyacetone phosphate precursor pools (U calc < U table ). In both experiments, C3 and C4 resonances can be resolved into singlet and doublet components, the doublet representing the [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose isotopomer (Fig. 2) . After subtraction of the NA contribution from the singlet signal, the ratio between the doublet and the total (singlet and correspondent doublet) provides the enrichment of the triose phosphate precursor pool (Fig. 1 and C-enrichment distribution of glucose represents all hepatic GNG activity involving carboxylation reactions of the Krebs cycle. With sufficient sample mass, the 13 C-NMR method can quantify very low excess 13 C-enrichment levels of [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose (13), the product generated from the GNG condensation of two 13 C-enriched triose phosphate molecules. This capability is an important consideration in the MIDA approach because the enrichment level of [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose cannot exceed the square of the enrichment of the triose phosphate precursor pool. Triose phosphate enrichment from [1- 13 C]lactate was found to be $25%. Given a mixture of 99% 1 mM [1-
13 C]lactate and 0.1 mM unlabeled pyruvate, the pyruvate pool should be $90% enriched. After carboxylation to oxaloacetic acid and randomization of 13 C between C4 and C1, enrichment at each carbon will be reduced by a factor of 2 to $45%. Assuming that net anaplerosis is about twice that of the Krebs cycle flux (15) , the oxaloacetic acid carboxyls will be further diluted by about two-thirds from the entry of unlabeled carbons derived from acetyl-CoA, resulting in a an enrichment of $30%. Recycling of PEP via pyruvate provides additional opportunity for exchange of labeled 13 C with unlabeled CO 2 , thereby reducing the 13 C enrichment of oxaloacetic acid carboxyls (19) . Therefore, the observed triose phosphate enrichment of $25% can be explained entirely by exchanges and dilutions at the Krebs cycle level. When these considerations are applied to the [ 13 C]bicarbonate label, we reach a different conclusion. Pyruvate carboxylation and randomization of oxaloacetic acid carbons will reduce the 13 C-labeled precursor enrichment to $50%, and dilution from acetyl-CoA will further reduce this to $33%. However, in this experiment, PEP recycling will increase the 13 C enrichment of oxaloacetic acid by providing additional opportunity for entry of [
13 C]bicarbonate via carboxylation. Hence, the triose phosphate enrichment would be expected to be at least 33%, substantially higher than the 20% enrichment that was measured. The most reasonable explanation for this discrepancy is that the [ 13 C]bicarbonate precursor was diluted by exchange with unlabeled CO 2 from the carbogen gas used to maintain oxygenation and pH of the perfusion fluid.
In the 2 H 2 O measurement, the ratio of H5/H2 enrichment approached unity, indicating that all GP was from GNG. H6/H2 ratios were significantly less, indicating that there was a substantial contribution of GNG from glycerol, an incomplete exchange between the precursor hydrogens and perfusion water, or most probably an incomplete backward scrambling between malate and fumarate. The H6 pair of glucose are derived from the methylene hydrogens of PEP and oxaloacetic acid and the methyl hydrogens of pyruvate. Unlike H5, which is enriched via the obligatory addition of water hydrogen via enolase or triose phosphate isomerase, 2 H incorporation into the H6 positions is contingent on exchanges at the level of the Krebs cycle and pyruvate. To the extent that these exchanges are incomplete, glucose H6 enrichment will be less than that of H5.
Sensitivity and practicality of 13 C NMR isotopomer distribution analysis in humans After overnight fasting, when GNG accounts for $50% of GP, a 4% enrichment of the triose phosphate precursor pool would result in a steady-state [3,4-13 C 2 ]glucose Table 1 . 13 C enrichment of glucose measured directly by 13 C NMR, calculated triose phosphate 13 C enrichment by 13 C NMR isotopomer distribution analysis, and the contribution of triose phosphate to GP from the [1- Excess enrichment levels of 2% in C3 and C4 can be precisely quantified if the NA signals of the other carbons have acceptable signal-to-noise ratios. In humans, hepatic Glc6P can be non-invasively sampled by glucuronidation probes such as paracetamol and menthol (10, 16) , and this approach has two key advantages for quantifying enrichment from GNG tracers compared with the analysis of plasma glucose. First, glucuronides provide higher amounts of analyte (>100 mmol) than a 20-30 mL blood collection. Second, the relatively small hepatic sugar phosphate pool sizes ensure that isotopic steady-state from GNG 13 C-labeled precursors is rapidly achieved. We think that the predicted 3,4-hexose 13 C-enrichment levels of 0.16% should be quantifiable from a urine glucuronide sample with reasonably short collection times (1-2 h) either by direct-detect 13 C NMR or by more sensitive indirect detection methods such as J-resolved heteronuclear single-quantum coherence spectroscopy (17) .
Given the dilutions at the Krebs cycle level (6), a 4% enrichment of [1- 13 C] bicarbonate administered was therefore $1 mmol. On this basis, 8% 13 C enrichment of plasma bicarbonate would require about 100 mmol (8.5 g) sodium [ 13 C]bicarbonate tracer. This quantity is comparable to the amounts of [1- 13 C]acetate or [2-13 C]glycerol used in human MIDA studies of lipogenesis and GNG (19, 20, 21) .
In conclusion, we studied the use of [ 
